197 related articles for article (PubMed ID: 26451530)
1. Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain.
De Francesco M; Ronco C; Wacinski PJ; Wessely R; Hernández F; Lamotte M
J Med Econ; 2016; 19(2):158-68. PubMed ID: 26451530
[TBL] [Abstract][Full Text] [Related]
2. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
Azzalini L; Vilca LM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Demir OM; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A
Int J Cardiol; 2018 Dec; 273():69-73. PubMed ID: 30196995
[TBL] [Abstract][Full Text] [Related]
3. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
[TBL] [Abstract][Full Text] [Related]
4. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
Reed MC; Moscucci M; Smith DE; Share D; LaLonde T; Mahmood SA; D'Haem C; McNamara R; Greenbaum A; Gurm HS
J Invasive Cardiol; 2010 Oct; 22(10):467-72. PubMed ID: 20944185
[TBL] [Abstract][Full Text] [Related]
5. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of intravenous iodinated contrast media in Italy.
Iannazzo S; Vandekerckhove S; De Francesco M; Nayak A; Ronco C; Morana G; Valentino M
Int J Technol Assess Health Care; 2014 Jan; 30(1):69-77. PubMed ID: 24485022
[TBL] [Abstract][Full Text] [Related]
7. Effects of a High Dose of the Contrast Medium Iodixanol on Renal Function in Patients Following Percutaneous Coronary Intervention.
Zhao N; Chen Z; Zhou Y; Xu Q; Xu Z; Tong W; Li L; Mao Q; Song Y; Jin J; Huang L; Azzalini L; Zhao X
Angiology; 2021 Feb; 72(2):145-152. PubMed ID: 32911955
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media.
Karlsberg RP; Dohad SY; Sheng R;
J Nephrol; 2010; 23(6):658-66. PubMed ID: 20540038
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
[TBL] [Abstract][Full Text] [Related]
10. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
[TBL] [Abstract][Full Text] [Related]
11. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Werner S; Bez C; Hinterleitner C; Horger M
PLoS One; 2020; 15(5):e0233433. PubMed ID: 32437415
[TBL] [Abstract][Full Text] [Related]
12. The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty.
Keuffel E; McCullough PA; Todoran TM; Brilakis ES; Palli SR; Ryan MP; Gunnarsson C
J Med Econ; 2018 Apr; 21(4):356-364. PubMed ID: 29226736
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
14. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
Karlsberg RP; Dohad SY; Sheng R;
J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
[TBL] [Abstract][Full Text] [Related]
15. Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.
Hiremath S; Akbari A; Wells GA; Chow BJW
Int Urol Nephrol; 2018 Aug; 50(8):1477-1482. PubMed ID: 29687326
[TBL] [Abstract][Full Text] [Related]
16. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
[TBL] [Abstract][Full Text] [Related]
18. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Briguori C; Visconti G; Ricciardelli B; Condorelli G;
EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686
[TBL] [Abstract][Full Text] [Related]
19. Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction.
Premawardhana D; Sekar B; Ul-Haq MZ; Sheikh A; Gallagher S; Anderson R; Copt S; Ossei-Gerning N; Kinnaird T
Minerva Cardioangiol; 2019 Oct; 67(5):380-391. PubMed ID: 31527583
[TBL] [Abstract][Full Text] [Related]
20. Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.
Zhang J; Jiang Y; Rui Q; Chen M; Zhang N; Yang H; Zhou Y
Medicine (Baltimore); 2018 May; 97(18):e0617. PubMed ID: 29718868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
